journal article·2016-09

Development and evaluation of a controlled drug delivery wound dressing based on polymeric porous microspheres

Muhammad Furqan Khurshid, Tanveer Hussain, Rashid Masood, Nisar Hussain

Journal of Industrial Textiles· Volume 46· Issue 3
Publisher page

Abstract

The aim of the present work was to develop and evaluate a controlled drug delivery wound dressing based on polymeric porous microspheres, which are also termed as microsponge drug delivery system. For this purpose, turmeric (drug)-based polymeric porous microspheres formulations were developed by quasi-emulsion solvent diffusion method. The production yields, actual drug content, drug entrapment efficiency, particle size, formulation of the material, and in vitro release were studied. On the basis of maximum drug released, a formulation was selected to incorporate into wound dressings with the help of a binder by spraying technique. Finally, the selected formulation and samples of wound dressings containing microsponges were subjected to scanning electron microscopy and drug release analyses. The result of in vitro release shows that microsponge drug delivery system is a versatile tool that has a potential to convert any wound dressing into a controlled drug delivery wound dressing.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Wound Healing and Treatments · Polymer Nanocomposite Synthesis and Irradiation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Textile Engineering, Bahauddin Zakariya University, Multan, Pakistan

National Textile University, Faisalabad, Pakistan

Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan

References (62)

Show source-provided references
1. Gupta B, Agarwal R, Alam MS. Textile-based smart wound dressings. Ind J Fibre Text Res 2010; 35: 174–187.
2. 10.1533/978184569630610.1533/9781845696306 ↗
3. 10.1002/jps.2121010.1002/jps.21210 ↗
4. Chien YW, Lin S. Drug delivery: Controlled release. Encycl Pharm Technol 2007; 1: 1082–1103.
5. 10.1515/aut-2002-02040210.1515/aut-2002-020402 ↗
6. Grigoriu A, Popescu O. Applications of cyclodextrines in textiles—a review. Polit Iaşi 2011; 11: 47–65.
7. Voncina B. Application of cyclodextrins in textile dyeing. Textile Dyeing www.intechopen.com 2011 pp. 373–392 (accessed February 2014).10.5772/19147 ↗
8. 10.1007/s10847-008-9456-y10.1007/s10847-008-9456-y ↗
9. Bakry R, Vallant RM, Haq MN, . Medicinal applications of fullerenes. Int J Nanomed 2007; 2: 639–649.
10. Nagda D, Rathore KS, Bharkatiya M, . Bucky balls: A novel drug delivery system. J Chem Pharm Res 2010; 2: 240–248.
11. Elahi F, Lu W, Guoping G, . Core-shell fibers for biomedical applications—a review. Bioeng Biomed Sci 2013; 3: 1–14.
12. 10.1002/pi.108610.1002/pi.1086 ↗
13. Zamani M, Prabhakaran MP, Ramakrishna S. Advances in drug delivery via electrospun and electrosprayed nanomaterials. Int J Nanomed 2013; 8: 2997–3017.
14. 10.1021/bm060057z10.1021/bm060057z ↗
15. 10.1088/1468-6996/11/1/01410810.1088/1468-6996/11/1/014108 ↗
16. 10.1002/pi.449910.1002/pi.4499 ↗
17. Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym 2011; 18: 1–26.
18. 10.1016/S0266-3538(03)00178-710.1016/S0266-3538(03)00178-7 ↗
19. 10.1016/j.addr.2004.05.00210.1016/j.addr.2004.05.002 ↗
20. 10.1089/ten.2006.12.119710.1089/ten.2006.12.1197 ↗
21. Arora N, Agarwal S, Murthy RSR. Review article latest technology advances in cosmaceuticals. Int J Pharm Sci Drug Res 2012; 4: 168–182.10.25004/IJPSDR.2012.040302 ↗
22. Wang CX, Chen SL. Aromachology and its application in the textile field. Fibres Text East Eur 2005; 13: 41–44.
23. Singh MK, Varun VK, Behera BK. Cosmetotextiles: State of art. Fibres Text East Eur 2011; 19: 27–33.
24. Shafi SK, Duraivel S, Bhowmik D, . Micrrosponge drug delivery system. Ind J Res Pharm Biotechnol 2013; 1: 206–209.
25. Ravali V, Spandana V, Shilpa T, . A review on microsponges drug delivery system. Int J Pharm Res Rev 2013; 1: 309–335.
26. Choudhari SJ, Singh SR. Microsponge—novel drug delivery system. Int J Med Pharm Sci Res Rev 2013; 1: 26–52.
27. Gandhi A, Jana S, Sen KK. Tailoring effect of microsponge for targeted drug delivery. J Sci Innov Res 2013; 2: 1073–1082.
28. Jadhav N, Patel V, Mungekar S, . Microsponge delivery system: An updated review, current status and future prospects. J Sci Innov Res 2013; 2: 1097–1110.
29. Yadev P, Nanda S. Development and evaluation of some microsponge loaded medicated topical formulations of Acyclovir. Int J Pharm Sci Res 2014; 5: 1395–1410.
30. Ravi R, Sk SK. Standarization of process parameters involved erythormycin microsponges by Quassi emulsion solvent diffusion method. Int J Pharm Dev Technol 2013; 3: 28–34.
31. Mayur K, Ramesh K, Nitin J, . Ethyl cellulose based microsponges delivery system for anti-fungal vaginal gels of tioconazole. J Drug Deliv Ther 2013; 3: 14–20.
32. Mohan V, Veena NM, Manjula BP. Formulation and evaluation of microsponges for topical drug delivery of mupirocin. Int J PharmTech Res 2013; 5: 1434–1440.
33. Yasmeen BR, Chakravarthi RN. Preperation and evaluation of microsponge loaded controlled release topical gel of Acylovir sodium. Int J Biopharm J 2012; 3: 96–102.
34. Saboji JK, Manvi FV, Gadad AP, . Formulation and evaluation of ketoconazole microsponge gel by Quassi emulsion solvent diffusion. J Cell Tissue Res 2011; 11: 2691–2696.
35. 10.2478/v10007-011-0022-610.2478/v10007-011-0022-6 ↗
36. Rekha U, Manjula BP. Formulation and evaluation of microsponges for topical delivery system of mometasone furoate. Int J Pharm Pharm Sci 2011; 3: 1–5.
37. Amrutiya N, Bajaj A, Madan M. Development of microsponges for topical delivery of mupirocin. Am Assoc Pharm Sci 2009; 10: 402–409.
38. John ID, More HN. Topical anti-inflammatory gels of fluocinolone acetonide entrapped in eudragit based microsponge delivery system. Res J Pharm Tech 2008; 1: 502–506.
39. 10.1016/j.micron.2007.06.01210.1016/j.micron.2007.06.012 ↗
40. Grimes E, Pearl E. A microsponge formulation of the treatment of melasma and postinflammatory hyperpigmentation. Ther Clin 2004; 74: 362–368.
41. Mishra MK, Shikhri M, Sharma R, . Optimization, formulation development and characterization of Eudragit RS 100 loaded microsponges and subsequent colonic delivery. Int J DRUG Discov Herb Res 2011; 1: 8–13.
42. 10.4314/tjpr.v9i1.5203910.4314/tjpr.v9i1.52039 ↗
43. Deore BV, Mahajan HS, Deore UV. Development and characterization of sustained release microspheres by quasi emulsion solvent diffusion method. Int J ChemTech Res 2009; 1: 634–642.
44. 10.1016/j.ijpharm.2006.03.02510.1016/j.ijpharm.2006.03.025 ↗
45. Gade R, Aparna A, Keerthi B, . Design and development of hydroxyzine hydrochloride controlled release tablets. Caribb J Sci Technol 2013; 1: 172–184.
46. Patel EK, Oswal RJ. Nanosponge and micro sponges: A novel drug delivery system. Int J Res Pharm Chem 2012; 2: 237–244.
47. Patil RS, Kemkar VU, Patil S. Microsponge drug delivery system: A novel dosage form. Am J PharmTech Res 2012; 2: 2249–3387.
48. Saroj PK. Microsponge as the versatile tool for drug delivery system. Int J Res Pharm Chem 2011; 1: 243–258.
49. Kirti D, Sushilkumar P. Solid porous microsphere: Emerging trend in pharmaceutical technology. Int J Pharma Bio Sci Rev 2011; 2: 364–377.
50. Jain N, Sharma PK, Banik A. Recent advances on microsponge delivery system. Int J Pharm Sci Rev Res 2011; 8: 13–23.
51. Shaha V, Jain H, Krishna J, . Microsponge drug delivery: A review. Int J Res Pharm 2010; 1: 212–218.
52. Wasnik S, Parmar P. The design of colon specific drug delivery system and different approches to treat colon disease. Int J Pharm Sci Rev Res 2011; 6: 167–177.
53. 10.3923/pjbs.2004.2055.206010.3923/pjbs.2004.2055.2060 ↗
54. 10.1016/j.dyepig.2004.05.00810.1016/j.dyepig.2004.05.008 ↗
55. Joshi M, Ali SW, Purwar R. Ecofriendly antimicrobial finishing of textiles using bioactive agents based on natural products. Indian J Fibre Text Res 2009; 34: 295–304.
56. Kumar A, Chomwal R, Kumar P, . Anti inflammatory and wound healing activity of Curcuma aromatica salisb extract and its formulation. J Chem Pharm Res 2009; 1: 304–310.
57. 10.1016/j.lfs.2005.12.00710.1016/j.lfs.2005.12.007 ↗
58. Purohit SK, Solanki R, Mathur V, . Evaluation of wound healing activity of ethanolic extract of Curcuma longa rhizomes in male albino rats. Asian J Pharm Res 2013; 3: 79–81.
59. Shimatsu A, Kakeya H, Imaizumi A, . Clinical application of ‘curcumin’, a multi-functional substance. Anti-Aging Med 2012; 9: 43–51.
60. 10.1016/S0014-827X(02)00007-110.1016/S0014-827X(02)00007-1 ↗
61. 10.1016/j.ijpharm.2013.10.04510.1016/j.ijpharm.2013.10.045 ↗
62. 10.1016/j.foodchem.2008.09.07210.1016/j.foodchem.2008.09.072 ↗